Overview

Oral Collagen for Rheumatoid Arthritis

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by swelling and inflammation of the joints. In RA, the immune system attacks a person's own cells inside joints, eventually leading to joint damage and disability. This study will determine if oral bovine type II collagen (bovine CII) will lead to decreased joint inflammation in RA patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Tennessee
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)